Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours (Q44755180)
Jump to navigation
Jump to search
scientific article published on 13 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours |
scientific article published on 13 March 2013 |
Statements
1 reference
Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours (English)
1 reference
Roy S Herbst
1 reference
Ashutosh K Pathak
1 reference
José Baselga
1 reference
Nasser Hanna
1 reference
Scott A Laurie
1 reference
Rastislav Bahleda
1 reference
Emiliano Calvo
1 reference
Jean-Pierre Armand
1 reference
Frances A Shepherd
1 reference
Christopher T Harbison
1 reference
David Berman
1 reference
Jong-Soon Park
1 reference
Steven Zhang
1 reference
Blisse Vakkalagadda
1 reference
John F Kurland
1 reference
13 March 2013
1 reference
1 reference
49
1 reference
8
1 reference
1815-1824
1 reference
Identifiers
1 reference
1 reference